Adimmune Corp (4142) — Cash Flow Quality Index
Adimmune Corp (4142) has a Cash Flow Quality Index of -1.24x as of September 2024. Operating cash flow of NT$-301.42 Million is below net income of NT$243.28 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Adimmune Corp (4142) investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Adimmune Corp Cash Flow Quality Index (2009–2022)
Historical Cash Flow Quality Index for Adimmune Corp across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Adimmune Corp (4142) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Adimmune Corp (2009–2022)
Year-by-year earnings quality comparison for Adimmune Corp. For live market cap and the full company financial profile, see 4142 market cap.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.87x | NT$-291.96 Million | NT$156.22 Million | ▲ +94.4% |
| 2021 | -33.64x | NT$-480.52 Million | NT$14.29 Million | ▼ -1834.6% |
| 2020 | 1.94x | NT$2.32 Billion | NT$1.20 Billion | ▼ -39.4% |
| 2010 | 3.20x | NT$516.39 Million | NT$161.31 Million | ▲ +214.0% |
| 2009 | 1.02x | NT$600.42 Million | NT$588.88 Million | — |